Free tool
FAERS Monitor: Ferrlecit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020955 or its brand name (Ferrlecit, Sodium Ferric Gluconate Complex). Reports on generic versions are filed under their own applications.
Reports
2,174
Serious
1,765
81% of reports
Hospitalization
925
Death reported
449
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea519
- vomiting463
- abdominal pain415
- dyspnoea397
- sepsis301
- general physical health deterioration293
- abdominal distension278
- off label use277
- hyponatraemia268
- ascites267
- multiple organ dysfunction syndrome265
- appendicitis263
- stress263
- appendicolith260
- constipation259
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 61 |
| 2005 | 55 |
| 2006 | 71 |
| 2007 | 48 |
| 2008 | 57 |
| 2009 | 97 |
| 2010 | 73 |
| 2011 | 82 |
| 2012 | 76 |
| 2013 | 70 |
| 2014 | 81 |
| 2015 | 83 |
| 2016 | 67 |
| 2017 | 68 |
| 2018 | 48 |
| 2019 | 93 |
| 2020 | 128 |
| 2021 | 174 |
| 2022 | 120 |
| 2023 | 175 |
| 2024 | 218 |
| 2025 | 138 |
| 2026 | 91 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,985 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| appendicolithSignal | 260 | 19824.5 | 16101.9 | 1,684,850 |
| appendicitisSignal | 263 | 280.2 | 249.8 | 70,879 |
| multiple organ dysfunction syndromeSignal | 265 | 91.4 | 81.6 | 23,402 |
| ascitesSignal | 267 | 88.7 | 79.2 | 22,877 |
| hyponatraemiaSignal | 268 | 46.3 | 41.3 | 11,796 |
| stressSignal | 263 | 35.4 | 31.6 | 8,760 |
| sepsisSignal | 301 | 26.2 | 23.6 | 7,282 |
| abdominal distensionSignal | 278 | 25.8 | 23.1 | 6,627 |
| general physical health deteriorationSignal | 293 | 24.6 | 22.1 | 6,618 |
| abdominal painSignal | 415 | 17.3 | 15.9 | 6,412 |
| constipationSignal | 259 | 11.5 | 10.3 | 2,496 |
| vomitingSignal | 463 | 9.5 | 8.8 | 3,606 |
| dyspnoeaSignal | 397 | 6.8 | 6.2 | 2,007 |
| nauseaSignal | 519 | 6.3 | 5.9 | 2,423 |
| off label useSignal | 277 | 3.1 | 2.7 | 399 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.